These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22490812)

  • 1. [Triptolide combined with irbesartan synergistically blocks podocyte injury in a type 2 diabetes rat model].
    Ma RX; Xu Y; Zhang J; Li YS; Liu LQ
    Zhonghua Nei Ke Za Zhi; 2012 Feb; 51(2):117-22. PubMed ID: 22490812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effects and mechanism of Tripterygium wilfordii Hook F combination with irbesartan on urinary podocyte excretion in diabetic nephropathy patients].
    Ma RX; Zhao N; Zhang W
    Zhonghua Nei Ke Za Zhi; 2013 Jun; 52(6):469-73. PubMed ID: 24059992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triptolide Improves Renal Injury in Diabetic Nephropathy Rats through TGF-β1/Smads Signal Pathway.
    Pang R; Gu D
    Endocr Metab Immune Disord Drug Targets; 2021; 21(10):1905-1911. PubMed ID: 34530721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irbesartan ameliorates diabetic nephropathy by reducing the expression of connective tissue growth factor and alpha-smooth-muscle actin in the tubulointerstitium of diabetic rats.
    Ren X; Guan G; Liu G; Liu G
    Pharmacology; 2009; 83(2):80-7. PubMed ID: 19065061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transforming growth factor-β1 regulates renal α3 and β1 integrin expressions in diabetic rats: a new insight into the renoprotective effect of irbesartan].
    Zhu Y; Shen J; Hu YY; Tang JL; Liu S
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jun; 31(6):1059-62. PubMed ID: 21690069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triptolide Alleviates Podocyte Epithelial-Mesenchymal Transition via Kindlin-2 and EMT-Related TGF-β/Smad Signaling Pathway in Diabetic Kidney Disease.
    Ren L; Wan R; Chen Z; Huo L; Zhu M; Yang Y; Chen Q; Zhang X; Wang X
    Appl Biochem Biotechnol; 2022 Feb; 194(2):1000-1012. PubMed ID: 34596829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of angiotensin receptor blocker on phenotypic alterations of podocytes in early diabetic nephropathy.
    Dai HY; Zheng M; Tang RN; Ni J; Ma KL; Li Q; Liu BC
    Am J Med Sci; 2011 Mar; 341(3):207-14. PubMed ID: 21326079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of irbesartan in prevention of renal lesion in streptozotocin-induced diabetic rats.
    Liu BC; Chen Q; Luo DD; Sun J; Phillips AO; Ruan XZ; Liu NF
    Acta Pharmacol Sin; 2003 Jan; 24(1):67-73. PubMed ID: 12511232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of angiotensin-II receptor blockers on podocyte damage and glomerular apoptosis in a rat model of experimental streptozotocin-induced diabetic nephropathy.
    Tunçdemir M; Oztürk M
    Acta Histochem; 2011 Dec; 113(8):826-32. PubMed ID: 21269661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with irbesatan may improve slit diaphragm alterations in rats with adriamycin-induced nephropathy.
    Wang N; Wei RB; Li P; Li QP; Yang X; Yang Y; Huang MJ; Wang R; Yin Z; Lv Y; Chen XM
    J Renin Angiotensin Aldosterone Syst; 2016; 17(2):1470320316646884. PubMed ID: 27169889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of integrin-linked kinase by angiotensin II receptor antagonist, irbesartan attenuates podocyte injury in diabetic rats.
    Dai HY; Zheng M; Tang RN; Ma KL; Ni J; Liu BC
    Chin Med J (Engl); 2012 Mar; 125(5):888-93. PubMed ID: 22490592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of angiotensin II receptor antagonist on rat podocyte injury in early diabetic nephropathy].
    Long HB; Zhong J; Wei LB; Zhou WD; Xu ZZ
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Apr; 27(4):505-8. PubMed ID: 17545045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triptolide inhibits oxidative stress and inflammation via the microRNA-155-5p/brain-derived neurotrophic factor to reduce podocyte injury in mice with diabetic nephropathy.
    Gao J; Liang Z; Zhao F; Liu X; Ma N
    Bioengineered; 2022 May; 13(5):12275-12288. PubMed ID: 35603354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of bone morphogenic protein 7 on nephrin expression and distribution in diabetic rat kidneys].
    Xiao HQ; Shi W; Zhang Y; Liang YZ
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Apr; 29(4):671-5. PubMed ID: 19403392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Regulatory Effect of Chinese Drugs for Stasis Removing and Collaterals Dredging on the Expres- sions of podocin and CD2AP in Podocyte Slit Diaphragm of Diabetic Nephropathy Rats].
    Fang J; Chen ZQ; Guo Q; Chen CY; Wang CN; Xie T; Sun R; Liu LF; Zhang X
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Jul; 36(7):835-841. PubMed ID: 30634212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of triptolide on the expression of RANTES in the renal tissue of diabetic nephropathy rats].
    Zhu JJ; Wang BF; Hong YZ; Yang XC
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Oct; 34(10):1231-7. PubMed ID: 25509268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of irbesartan on renal hypertrophy and thickening of glomerular basement-membrane in streptozotocin-induced diabetic rats].
    Liu BC; Luo DD; Sun J; Ma KL; Ruan XZ
    Zhonghua Nei Ke Za Zhi; 2003 May; 42(5):320-3. PubMed ID: 12882713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triptolide Attenuates Renal Tubular Epithelial-mesenchymal Transition Via the MiR-188-5p-mediated PI3K/AKT Pathway in Diabetic Kidney Disease.
    Xue M; Cheng Y; Han F; Chang Y; Yang Y; Li X; Chen L; Lu Y; Sun B; Chen L
    Int J Biol Sci; 2018; 14(11):1545-1557. PubMed ID: 30263007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of irbesartan on the antioxidant defence system and nitric oxide release in diabetic rat kidney.
    Anjaneyulu M; Chopra K
    Am J Nephrol; 2004; 24(5):488-96. PubMed ID: 15353911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triptolide prevents extracellular matrix accumulation in experimental diabetic kidney disease by targeting microRNA-137/Notch1 pathway.
    Han F; Wang S; Chang Y; Li C; Yang J; Han Z; Chang B; Sun B; Chen L
    J Cell Physiol; 2018 Mar; 233(3):2225-2237. PubMed ID: 28695984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.